Biofil Chemicals

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
30.72
1.01 (3.4%)
BSENSE

Nov 20

BSE+NSE Vol: 28.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
JFL Life
Kabra Drugs
Ajooni Biotech
ANG Lifesciences
Mangalam Drugs
Rajnish Wellness
Phaarmasia
Vasundhara Rasy.
Biofil Chemicals
Chandra Bhagat
Onyx Biotec
Why is Biofil Chemicals & Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with a -17.14% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.50
  • The company has been able to generate a Return on Equity (avg) of 5.17% signifying low profitability per unit of shareholders funds
2
Negative results in Sep 26
  • NET SALES(Latest six months) At Rs 14.02 cr has Grown at -29.79%
  • PAT(Latest six months) At Rs 0.23 cr has Grown at -29.79%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 0.58 times
3
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
With ROE of 2.4, it has a Very Expensive valuation with a 2.3 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -21.15%, its profits have fallen by -81.8%
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -21.15% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biofil Chemicals for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Biofil Chemicals
-21.15%
-0.36
59.12%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-9.28%
EBIT Growth (5y)
-17.14%
EBIT to Interest (avg)
0.50
Debt to EBITDA (avg)
0.81
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.67
Tax Ratio
41.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
3.29%
ROE (avg)
5.17%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
96
Industry P/E
40
Price to Book Value
2.30
EV to EBIT
50.14
EV to EBITDA
50.14
EV to Capital Employed
2.29
EV to Sales
2.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.28%
ROE (Latest)
2.39%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
NET SALES(Latest six months)

At Rs 14.02 cr has Grown at -29.79%

PAT(Latest six months)

At Rs 0.23 cr has Grown at -29.79%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.58 times

PBT LESS OI(Q)

Lowest at Rs 0.02 cr.

Loading Valuation Snapshot...
Here's what is not working for Biofil Chemicals
Net Sales - Latest six months
At Rs 14.02 cr has Grown at -29.79%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
At Rs 0.23 cr has Grown at -29.79%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.02 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 0.58 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio